EUVIMEDEUVIMED entdecken
Validierungsstudie

Effects of gut microbiome on type 1 diabetes susceptibility and complications: A large‐scale bidirectional Mendelian randomization and external validation study

Keyu Guo iD, Jianan Ye iD, Jiaqi Li, Juan Huang, Zhiguang Zhou iD

Diabetes, Obesity and Metabolism · 2024

DOI: 10.1111/dom.15658 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Diabetes, Obesity and Metabolism, 2024. Verfasst von Keyu Guo und 4 weiteren Autor:innen. Beteiligte Einrichtung: National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, an…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Gastrointestinal Microbiome, Mendelian Randomization Analysis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of the Hunan province of China, Yale Diabetes Research Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To assess and verify the effect of the gut microbiome on the susceptibility and complications of type 1 diabetes (T1D). Materials and Methods To achieve this aim, a two‐sample and reverse Mendelian randomization (MR) analysis was conducted. In addition, an external validation study was performed using individual microbiome data of patients with T1D from the gutMEGA datasets and the National Clinical Research Center for Metabolic Diseases. The circulating metabolites facilitated two‐sample MR analysis, mediation and multivariable MR analysis to evaluate the direct relationship between the gut microbiome and T1D complications.

Results

The MR analysis results from the discovery and validation phases confirmed that Veillonellaceae can potentially reduce the susceptibility of T1D. In the gutMEGA dataset, the average relative abundance of Veillonellaceae in patients with T1D was 0.66%, compared with 1.09% in the controls. Furthermore, the external validation, which included 60 patients with T1D and 30 matched healthy controls, found that the median relative abundance of Veillonellaceae was also lower than controls at 1.10% (95% CI 0.50%‐1.80%). Specifically, the Eubacterium coprostanoligenes group, known for its ability to regulate cholesterol, was significantly associated with a lower risk of developing renal, neurological and ophthalmic complications in T1D. Moreover, high cholesterol in small high‐density lipoprotein and cholesteryl esters in high‐density lipoprotein were associated with a reduced risk of T1D renal and ophthalmic complications. The mediation and multivariable MR analysis combining cholesterol indicated that the E. coprostanoligenes group is the most dominant factor influencing T1D complications.

Conclusions

Our findings supported the potential causal effect of gut microbiota on the susceptibility and complications of T1D.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1Gastrointestinal MicrobiomeMendelian Randomization AnalysisHumansMaleFemaleAdultDisease SusceptibilityDiabetes Complications

Stichwörter der Autor:innen

cholesterolcomplicationgut microbial taxagut microbiotatype 1 diabetes

Autor:innen und Institutionen

  • National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, and Department of Metabolism and Endocrinology, The Second Xiangya Hospi…
  • Section of Endocrinology, Department of Internal Medicine, School of Medicine, Yale University, New Haven, Connecticut, USA.

ORCID-Profile: Keyu Guo, Jianan Ye, Zhiguang Zhou

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of the Hunan province of China
  • Yale Diabetes Research Center

Zitieren

APA

Guo, K., Ye, J., Li, J., Huang, J., & Zhou, Z. (2024). Effects of gut microbiome on type 1 diabetes susceptibility and complications: A large‐scale bidirectional Mendelian randomization and external validation study. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.15658

Vancouver

Guo K, Ye J, Li J, Huang J, Zhou Z. Effects of gut microbiome on type 1 diabetes susceptibility and complications: A large‐scale bidirectional Mendelian randomization and external validation study. Diabetes, Obesity and Metabolism. 2024. doi:10.1111/dom.15658

BibTeX
@article{Guo2024,
  author = {Guo, Keyu and Ye, Jianan and Li, Jiaqi and Huang, Juan and Zhou, Zhiguang},
  title = {Effects of gut microbiome on type 1 diabetes susceptibility and complications: A large‐scale bidirectional Mendelian randomization and external validation study},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2024},
  doi = {10.1111/dom.15658}
}
Kostenlos starten →